- All Targets
- Angiogenesis/Tyrosine Kinase
- Cell Cycle/Checkpoint
- HDAC
- Apoptosis
- PARP
- Aurora/Ksp
- MAPK
- PI3K/Akt/mTOR
- Hormone
- Integrase/CCR5
- Proteases/HSP90/HSP70
- Wnt/Hedgehog/Notch
- Jak/Stat
- Ca/cAMP/Lipid Signaling
- Neuro Signaling
- TGF-beta/Smad Signaling
- GPCR
- SCTR
- SSTR
- CRF receptor
- GCGR
- GHSR
- GRF-R
- Ghrelin receptor
- tachykinin NK1 receptor
- vasopressin receptor
- Angiotensin receptor
- CB1 receptor
- CB2 receptor
- OX receptor
- Beta-1 adrenergic receptor
- Smoothened (Smo)
- Alpha-1 receptor
- A2A adenosine receptor
- mGluR2/mGluR3
- PTGFR
- SGLT
- Opioid receptor
- Dopamine receptor
- Beta-2 adrenergic receptor
- Serotonin receptor
- Muscarinic receptor
- Ion channel
- Cytochrome P450
- Others
- Cancer
- Infection
- Endocrinology
- Metabolic Disease
- Inflammation
- Immunology
- Neurological Disease
- Cardiovascular Disease
Cyclopamine
(Synonyms11-deoxojervine
)Add to Favor
M.Wt: 411.62
Formula: C27H41NO2
Solubility: DMSO
Purity: >99%
Storage: at -20℃ 2 years
CAS No.: 4449-51-8
Price and Availability of Cyclopamine:
Biological Activity of Cyclopamine:
Cyclopamine inhibits the hedgehog signaling pathway (Hh) by influencing the balance between the active and inactive forms of the Smoothened protein. The hedgehog signaling pathway carries out important functions in embryonic development and when it goes awry, deformities can occur. However, errant activation of the pathway can also trigger cancer in adult humans. [1]
Cyclopamine is a lipophilic compound extracted from the lily Veratrum californicum. It antagonizes Smo activity by binding to its heptahelical bundle. Thus, it can block pathway activation resulting in any of the two upstream events of Smo—i.e., either from PTCH mutations or from Hh ligand over-expression. Cyclopamine is currently being investigated as a treatment agent in basal cell carcinoma, medulloblastoma, and rhabdomyosarcoma, tumors connected to excessive Hh activity,etc. [2]
In preclinical models of rodent and human prostate cancer, cyclopamine can inhibit tumor growth as well as tumor progression. Administration of cyclopamine causes both down-regulation of proliferation and initiation of apoptosis, with consequent reduction in tumor size. Administration of cyclopamine in a lethal, metastatic rodent model of prostate cancer completely abrogates systemic metastases and dramatically improves survival. [3]
References on Cyclopamine:
[1] Chen JK et al. Genes Dev. 2002 Nov 1;16(21):2743-8
[2] Kumar SK et al. Bioorg Med Chem. 2008 Mar 15;16(6):2764-8
HedgehogWe give free samples and rewards to people who would like to provide us useful scientific data(western blot, etc.) See Details
Find Multiple Products by Catalog Number
| Dongfeng Chen, The Rausing Lab |
| "Your product U0126(Cat.NO S1102) works well in our experiments. I hope I can get more excellent products from your company in future." |
| R.B. Cambridge |
| "I have used the chemical that I bought from you(Selleck,PTC-124) and it worked well.So we will eventually be ordering more." |
| Zhenghe John Wang Assistant Professor, Case Western Reserve University |
| "We have purchased LBH-589, Saha and MS-275 from you and they all worked well." |
| Jenny Sun |
| "We used the LBH-589 in our experiments. The compound is easy to use with excellent reproducibility." |
| Yu Wang, Harvard University |
| "The GDC0449 compound worked very well. The results in my hands are equally good as what's been published. Thanks for this great resource for our research." |
| Dung-Fang Lee |
| "Based on our preliminary data, I found MLN8237 and VX-680 have good effects in inhibiting Aurka-maintaining ESC self-renewal in mouse ES cells." |
| Jun 2011 Selleck Latest Catalog | ![]() |

